Detalhe da pesquisa
1.
Endocrine Disorders and COVID-19.
Annu Rev Med
; 74: 75-88, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151047
2.
Aging versus youth: Endocrine aspects of vulnerability for COVID-19.
Rev Endocr Metab Disord
; 23(2): 185-204, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860905
3.
Investigation of taste function and eating behavior in women with polycystic ovary syndrome.
Appetite
; 168: 105776, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710484
4.
Impact of social isolation during COVID-19 pandemic on health behaviors and weight management in women with polycystic ovary syndrome.
Eat Weight Disord
; 27(7): 2407-2413, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35195885
5.
Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Clin Endocrinol (Oxf)
; 91(6): 810-815, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31556132
6.
Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
Reprod Biomed Online
; 39(3): 522-529, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182353
7.
Is muscle mechanical function altered in polycystic ovary syndrome?
Arch Gynecol Obstet
; 300(3): 771-776, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263987
8.
Structural imaging of the brain reveals decreased total brain and total gray matter volumes in obese but not in lean women with polycystic ovary syndrome compared to body mass index-matched counterparts.
Gynecol Endocrinol
; 33(7): 519-523, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28277117
9.
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Hum Reprod
; 31(12): 2841-2855, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664216
10.
[Turkish Hypertension Consensus Report]. / Türk Hipertansiyon Uzlasi Raporu.
Turk Kardiyol Dern Ars
; 43(4): 402-9, 2015 Jun.
Artigo
em Turco
| MEDLINE | ID: mdl-26142798
11.
The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.
Endocrine
; 84(1): 287-292, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141060
12.
Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome.
Maturitas
; 185: 107982, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579578
13.
EndoBridge 2023: highlights and pearls.
Hormones (Athens)
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619812
14.
Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.
Clin Endocrinol (Oxf)
; 78(1): 120-5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22702394
15.
Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy.
Med Sci Monit
; 19: 210-5, 2013 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23518675
16.
25-OH-Vitamin D and procalcitonin levels after correction of acute hyperglycemia.
Med Sci Monit
; 19: 264-8, 2013 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23580106
17.
Current and emerging drug treatment strategies for polycystic ovary syndrome.
Expert Opin Pharmacother
; 24(1): 105-120, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35912829
18.
Interleukin-22/Interleukin-22 binding protein axis and oral contraceptive use in polycystic ovary syndrome.
Endocrine
; 81(1): 54-57, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012532
19.
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Hum Reprod
; 27(10): 3067-73, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22777527
20.
Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome.
Hum Reprod
; 26(12): 3339-45, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21984577